{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:07:11Z","timestamp":1795147631069,"version":"4.10.3"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The incidence of stroke may be increased in patients with coronary artery disease (CAD). We aimed to investigate the specific risk factors for the development of ischaemic and haemorrhagic stroke in stable CAD patients.<\/jats:p>\n            <jats:p>Patients with stable CAD were prospectively enrolled for future cardiovascular events in Taiwan. All the patients had received coronary interventions and were stable for least 1\u200amonth before enrolment. The incidence of ischaemic stroke was identified and confirmed by telephone and hospital records. Baseline characteristics, including demographic data, lipid profiles, medications, and biomarkers for potential inflammatory and atherosclerosis, were analysed.<\/jats:p>\n            <jats:p>In total, 1428 patients (age, 63.07\u200a\u00b1\u200a11.4\u200ayears; 1207 males) were under standard medical treatment and regularly followed-up for at least 4\u200ayears. Multivariate logistic regression analysis showed that baseline serum myeloperoxidase (MPO) level (hazard ratio [HR]: 1.89, 95% CI: 1.16\u20133.10, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.01) and statin use (HR: 0.37; 95% CI: 0.17\u20130.79, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.01) were independently associated with the onset of ischaemic stroke. Age (HR: 1.07, 95% CI: 1.00\u20131.14, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.04) and angiotensin receptor blocker (ARB) use (HR: 0.37, 95% CI: 0.17\u20130.79, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.01) were independently associated with future onset of intracranial haemorrhage (ICH), implying the different mechanisms of ischaemic stroke and ICH.<\/jats:p>\n            <jats:p>Age and ARB use were related to ICH onset. Baseline MPO level and statin use were independently associated with longer and shorter future ischaemic stroke onset in stable CAD patients, respectively. Further studies are indicated to confirm the potential mechanisms and advance individual risk stratification for the onset of different types of stroke in clinical CAD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027973","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T13:16:38Z","timestamp":1638537398000},"page":"e27973","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2064-9523","authenticated-orcid":false,"given":"Wei-Ting","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."},{"name":"Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."},{"name":"From the Divison of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan, R.O.C."},{"name":"School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Cheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."},{"name":"From the Divison of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Kung","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging and Radiological Sciences, I-Shou University, Kaohsiung, Taiwan, R.O.C."},{"name":"Division of Cardiology, Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[{"name":"Cardiology Division of Cardiovascular Medical Center and Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan, R.O.C"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsien","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-I","family":"Yeh","sequence":"additional","affiliation":[{"name":"Mackay Memorial Hospital, Mackay Medical College, New Taipei City, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Cheng","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C"},{"name":"Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan, R.O.C"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hung","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Buddhist Tzu-Chi General Hospital, Tzu-Chi University, Hualien, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Bang","family":"Leu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."},{"name":"Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."},{"name":"From the Divison of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan, R.O.C."},{"name":"Heath Care and Management Center (H.-B.L., J.-W.C.), Taipei Veterans General Hospital, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsian","family":"Yin","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."},{"name":"Division of Cardiology, Heart Center, Cheng-Hsin General Hospital, Taipei, Taiwan, R.O.C"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Chung","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan, R.O.C."},{"name":"Department of Primary Care Medicine, College of Medicine, National Taiwan University, Taipei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."},{"name":"From the Divison of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan, R.O.C."},{"name":"Heath Care and Management Center (H.-B.L., J.-W.C.), Taipei Veterans General Hospital, Taiwan"},{"name":"Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjcard.2018.09.011","article-title":"Comparison of frequency of ischemic stroke in patients with versus without coronary heart disease and without atrial fibrillation","volume":"123","author":"Olesen","year":"2019","journal-title":"Am J Cardiol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"104400","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104400","article-title":"Coronary artery disease in patients with ischemic stroke and TIA","volume":"28","author":"Bhatia","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1097\/CM9.0000000000001645","article-title":"Impact of prior cerebrovascular events on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or percutaneous coronary intervention","volume":"134","author":"Pan","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Emerging Risk Factors","year":"2010","journal-title":"Lancet"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2019.02.022","article-title":"Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease","volume":"493","author":"Ndrepepa","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1161\/STROKEAHA.112.656744","article-title":"Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study","volume":"43","author":"Romero","year":"2012","journal-title":"Stroke"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12883-019-1375-6","article-title":"Biomarkers of immune capacity, infection and inflammation are associated with poor outcome and mortality after stroke - the PREDICT study","volume":"19","author":"Mengel","year":"2019","journal-title":"BMC Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Emerging Risk Factors","year":"2009","journal-title":"JAMA"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"15427","DOI":"10.1038\/s41598-017-14692-3","article-title":"Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection","volume":"7","author":"Lyu","year":"2017","journal-title":"Sci Rep"},{"key":"R12-20250504","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Fibrinogen Studies","year":"2005","journal-title":"JAMA"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations","volume":"113","author":"Vasan","year":"2006","journal-title":"Circulation"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12872-018-0991-1","article-title":"Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12872-017-0471-z","article-title":"Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan","volume":"17","author":"Leu","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.3390\/ijms21239245","article-title":"Fatty-acid-binding protein 4 as a novel contributor to mononuclear cell activation and endothelial cell dysfunction in atherosclerosis","volume":"21","author":"Wu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1038\/s41598-020-61894-3","article-title":"Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease","volume":"10","author":"Wu","year":"2020","journal-title":"Sci Rep"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"14410","DOI":"10.1038\/s41598-018-32210-x","article-title":"The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease","volume":"8","author":"Ho","year":"2018","journal-title":"Sci Rep"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions","volume":"363","author":"Collins","year":"2004","journal-title":"Lancet"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.108.813311","article-title":"Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation","volume":"119","author":"Liu","year":"2009","journal-title":"Circulation"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2017.06.007","article-title":"Association of the serum myeloperoxidase\/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study","volume":"263","author":"Khine","year":"2017","journal-title":"Atherosclerosis"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12944-018-0718-4","article-title":"Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease","volume":"17","author":"Kimak","year":"2018","journal-title":"Lipids Health Dis"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1212\/WNL.0000000000009179","article-title":"Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort study","volume":"95","author":"Maestrini","year":"2020","journal-title":"Neurology"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/01.STR.0000080678.09344.8D","article-title":"Risk factors for intracerebral hemorrhage in the general population: a systematic review","volume":"34","author":"Ariesen","year":"2003","journal-title":"Stroke"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/01.STR.16.5.860","article-title":"Brain metabolic changes in young vs aged rats during hypoxia","volume":"16","author":"Hoffman","year":"1985","journal-title":"Stroke"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1161\/STROKEAHA.114.006433","article-title":"Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke","volume":"45","author":"Jusufovic","year":"2014","journal-title":"Stroke"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2014-308948","article-title":"Preadmission use of ACE inhibitors or angiotensin receptor blockers and short-term mortality after stroke","volume":"86","author":"Sundb\u00f8ll","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1474-4422(12)70104-7","article-title":"Intracerebral haemorrhage: mechanisms of injury and therapeutic targets","volume":"11","author":"Keep","year":"2012","journal-title":"Lancet Neurol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jamaneurol.2020.1512","article-title":"Assessment of incidence and risk factors of intracerebral hemorrhage among participants in the Framingham heart study between 1948 and 2016","volume":"77","author":"Lioutas","year":"2020","journal-title":"JAMA Neurol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12975-019-00727-6","article-title":"Stroke center care and outcome: results from the CSPPC stroke program","volume":"11","author":"Shen","year":"2020","journal-title":"Transl Stroke Res"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1747493020913557","article-title":"Stroke prevention and control system in China: CSPPC-Stroke Program","volume":"16","author":"Chao","year":"2021","journal-title":"Int J Stroke"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/1747493019873706","article-title":"Multi-level community interventions for primary stroke prevention: a conceptual approach by the World Stroke Organization","volume":"14","author":"Brainin","year":"2019","journal-title":"Int J Stroke"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1001\/jama.296.24.2939","article-title":"Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50\u200ayears","volume":"296","author":"Carandang","year":"2006","journal-title":"JAMA"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.110.936526","article-title":"Get with the guidelines-stroke performance indicators: surveillance of stroke care in the Taiwan stroke registry: get with the guidelines-stroke in Taiwan","volume":"122","author":"Hsieh","year":"2010","journal-title":"Circulation"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(13)61088-0","article-title":"Intracranial atherosclerosis","volume":"383","author":"Qureshi","year":"2014","journal-title":"Lancet"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"e0186861","DOI":"10.1371\/journal.pone.0186861","article-title":"Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? \u2013 Data from a multicenter registry cohort study in Taiwan","volume":"12","author":"Yeh","year":"2017","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:37:55Z","timestamp":1746333475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":41,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027973","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"2021-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}